Staar Surgical (STAA) EBT Margin (2010 - 2026)
Staar Surgical's (STAA) quarterly EBT Margin came in at 11.79% in Q3 2026, up 7026.0% on a YoY basis from 0.17% in Q3 2025, and up 34.13% quarter-over-quarter from 8.79% in Q2 2026.
Powered by 
Analysis
Staar Surgical (STAA) EBT Margin (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has reported EBT Margin for 17 consecutive years, with 11.79% the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, EBT Margin rose 7026.0% year-over-year to 11.79%; the trailing twelve-month figure through Jul 2026 stood at 5.12% (up 6811.0% YoY), and the FY2026 full-year result was 34.36%, down 1752.0% from the prior year.
- EBT Margin grew to 11.79% in Q3 2026 per STAA's latest filing, from 8.79% in the prior quarter.
- Across five years, EBT Margin topped out at 164.15% in Q4 2022 and bottomed at 151.46% in Q4 2024.
- Historically, EBT Margin has averaged 0.56% across 5 years, with a median of 9.82% in 2023.
- The sharpest annual moves came in 2024 and 2026: EBT Margin slumped 23029 bps in 2024, then surged 13672 bps in 2026.
- Over 5 years, EBT Margin stood at 164.15% in 2022, then plunged by 52 bps to 78.83% in 2023, then tumbled by 292 bps to 151.46% in 2024, then soared by 113 bps to 19.83% in 2025, then sank by 41 bps to 11.79% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 11.79%, 8.79%, and 35.73% for Q3 2026, Q2 2026, and Q1 2026 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Staar Surgical | 1.18 Bn | 996.53 Mn | 69.73 Mn | 11.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 11.79% |
| Apr 3, 2026 | 8.79% |
| Jan 2, 2026 | -35.73% |
| Sep 26, 2025 | 19.83% |
| Jun 27, 2025 | -58.47% |
| Mar 28, 2025 | -127.93% |
| Dec 27, 2024 | -151.46% |
| Sep 27, 2024 | 14.85% |
| Jun 28, 2024 | 10.44% |
| Mar 29, 2024 | -2.86% |
| Dec 29, 2023 | 78.83% |
| Sep 29, 2023 | 8.40% |
| Jun 30, 2023 | 9.20% |
| Mar 31, 2023 | 6.42% |
| Dec 30, 2022 | 164.15% |
| Sep 30, 2022 | 16.54% |
| Jul 1, 2022 | 19.07% |
| Apr 1, 2022 | 18.24% |
| Dec 31, 2021 | 38.20% |
| Oct 1, 2021 | 12.64% |